These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24488527)

  • 21. Conservative treatment of overanticoagulated patients.
    Glover JJ; Morrill GB
    Chest; 1995 Oct; 108(4):987-90. PubMed ID: 7555174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous bladder rupture secondary to warfarin overdose: a case report.
    Sahin T; Oner U; Baser O; Kurtuncu I
    BMC Emerg Med; 2019 Dec; 19(1):80. PubMed ID: 31849327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.
    Crowther MA; Douketis JD; Schnurr T; Steidl L; Mera V; Ultori C; Venco A; Ageno W
    Ann Intern Med; 2002 Aug; 137(4):251-4. PubMed ID: 12186515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin K1 and therapy of massive warfarin overdose.
    Shearer MJ; Barkhan P
    Lancet; 1979 Feb; 1(8110):266-7. PubMed ID: 84915
    [No Abstract]   [Full Text] [Related]  

  • 26. [Overdose in Vitamin K antagonists administration in Dakar: epidemiological, clinical and evolutionary aspects].
    Dia K; Sarr SA; Mboup MC; Ba DM; Fall PD
    Pan Afr Med J; 2016; 24():186. PubMed ID: 27795783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer.
    Pritchard ER; Murillo JR; Putney D; Hobaugh EC
    J Oncol Pharm Pract; 2019 Jan; 25(1):52-59. PubMed ID: 28825375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phytonadione therapy in a multiple-drug overdose involving warfarin.
    Bates D; Mintz M
    Pharmacotherapy; 2000 Oct; 20(10):1208-15. PubMed ID: 11034045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center.
    Levine M; Curry SC; Padilla-Jones A; Ruha AM
    Ann Emerg Med; 2013 Sep; 62(3):252-8. PubMed ID: 23642908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of anticoagulant poisoning.
    Isbister GK; Whyte IM
    Vet Hum Toxicol; 2001 Apr; 43(2):117. PubMed ID: 11308119
    [No Abstract]   [Full Text] [Related]  

  • 32. Management and Outcomes of Bleeding Events in Patients in the Emergency Department Taking Warfarin or a Non-Vitamin K Antagonist Oral Anticoagulant.
    Singer AJ; Quinn A; Dasgupta N; Thode HC
    J Emerg Med; 2017 Jan; 52(1):1-7.e1. PubMed ID: 27793500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
    Hanslik T; Prinseau J
    Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to oral vitamin K for reversal of overanticoagulation during Crohn's disease relapse.
    Fugate SE; Ramsey AM
    J Thromb Thrombolysis; 2004 Jun; 17(3):219-23. PubMed ID: 15353921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage.
    Sarode R; Matevosyan K; Bhagat R; Rutherford C; Madden C; Beshay JE
    J Neurosurg; 2012 Mar; 116(3):491-7. PubMed ID: 22175718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience with oral versus intravenous vitamin K for warfarin reversal.
    Meehan R; Tavares M; Sweeney J
    Transfusion; 2013 Mar; 53(3):491-8; quiz 490. PubMed ID: 22738309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
    Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
    Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A survey of oral vitamin K use by anticoagulation clinics.
    Libby EN; Garcia DA
    Arch Intern Med; 2002 Sep; 162(16):1893-6. PubMed ID: 12196089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.